A comparative study of nucleolar organizer regions proliferating cell nuclear antigen and epidermal growth factor receptor staining in colon tumours

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 8, 1998, Pages 794-800

  Shimada, Naoki ^a   Suzuki, Junichi ^a   Fujita, Jun ^a   Kawakami, Yoshikazu ^a   Tsukakoshi, Hiromoto ^b   Hosokawa, Masao ^b   Sato, Noriyuki ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Ag NOR; Colon tumour; EGF R; PCNA; Proliferative activity

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CHROMOSOME NOR; COLON TUMOR; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 0031830997     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00735.x     Document Type: Article

References (34)

1. Gerdes J, Stein H, Pirei S et al. Prognostic relevance of tumor-cell fraction in malignant non-Hodgkin's lymphomas. Lancet 1987; 2: 448-9.
2. Conte PF, Alama A, Rubagotti A et al. Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy and survival. Cancer 1989; 64: 1188-91.
3. Anti M, Marra G, Armelao F et al. Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut 1993; 34: 525-30.
4. Goran J, Goran R. Antibody to proliferating cell nuclear antigen as S-phase probes in the cytometric cell cycle. Cancer Res. 1991; 51: 4570-4.
5. Wilson RG, Smith AN, Bird CC. Immunochemical detection of abnormal cell proliferation in colonic mucosa of subjects with polyps. J. Clin. Pathol. 1990; 43: 744-7.
6. Porschen R, Lohe B, Hengels KJ, Borchard F. Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki-67; correlation with pathologic criteria and influence of irradiation. Cancer 1989; 64: 2501-5.
7. Nelsen AL, Nyholm HC. Proliferating cell nuclear antigen in endometrial adenocarcinomas of endometrioid type correlate with histologic grade, stage, previous hormonal treatment and survival. Hum. Pathol. 1993; 24: 1003-7.
8. Russel DL, Malcolm RA, Catherine ES. Variation in the occurrence of silver-staining nucleolar organizer regions (Ag-NORs) in non-proliferating and proliferating tissues. J. Pathol. 1991; 165: 43-51.
9. Das BC, Rani R, Mitra AB, Luthra UK. The number of silver-staining NORs (rDNA) in lymphocytes of newborns and its relationship to human development. Meeh. Age Dev. 1986; 4: 117-23.
10. Ogura S, Abe S, Sukoh N et al. Correlation between nucleolar organizer regions visualized by silver staining and growth rate in lung adenocarcinoma. Cancer 1992; 70: 63-8.
11. Ploton D, Mesager M, Jeannesson P, Himber G, Adnett JJ. Improvement in the staining and in visualization of argyrophilic proteins of nucleolar organizer regions at the optical level. Histochem. J. 1986; 18: 5-14.
12. Evan GI, Lewis GK, Ramsey G, Bishop JM. Isolation of monoclonal antibody specific for human c-myc protooncogene product. Mol. Cell. Biol. 1985; 5: 3610-16.
13. Shelly AS, James RD, Ranjana PB. Colonic aberrant foci are associated with increased expression of c-fos:The possible role of modified c-fos expression in preneoplastic lesions in colon cancer. Carcinogenesis 1992; 13: 573-8.
14. Yasui W, Hata J, Yokozaki H et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int. J. Cancer 1988; 41: 211-17.
15. Rothbauer E, Mann K, Wiebecke B et al. Epidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas. Klin. Wochenschr. 1989; 67: 518-23.
16. Stocheck CM, King LE Jr. Role of epidermal growth factor in carcinogenesis. Cancer Res. 1986; 46: 1030-7.
17. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985; 313: 745-7.
18. Landberg G, Tan EM, Roos G. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: A new view of the cell cycle. Exp. Cell. Res. 1990; 187: 655-61.
19. Morson BC, Dawson IMP. Gastrointestinal Pathology, 3rd edn, Oxford: Blackwell Scientific Publications, 1990; 563-96.
20. Simpson WC, Mayo CW. The mural penetration of carcinoma cell in the colon. Anatomical and clinical study. Surg. Gynecol. Obstet. 1939; 68: 872-7.
21. Reeves JR, Richards RC, Cooke T. The effects of intracolonic EGF on mucosal growth and experimental carcinogenesis. Br. J. Cancer 1991; 63: 223-6.
22. Yamagiwa H, Onishi N, Onishi T et al. Immunohistochemical study of PCNA, EGF-R, c-erbB-2 and p-53 in carcinoma of large intestine. Jpn J. Clin. Pathol. 1995; 43: 703-7 (in Japanese).
23. Abe S, Ogura S, Kunikanc K et al. Nucleolar organizer regions in precancerous and cancerous lesions of the bronchus. Cancer 1991; 67: 472-5.
24. Steele RJC, Kelly P, Ellul B, Eremin O. Immunohistochemical detection of epidermal growth factor receptor on human colonie carcinomas. Br. J. Cancer 1990; 61: 325-6.
25. Shimada N, Ogura S, Fujita J et al. Analysis of nucleolar organizer regions in colonic neoplasms. Gastroenterol. Endosc. 1993; 35: 2144-9 (in Japanese).
26. Yang P, Huang GS, Zhu XS. Role of nucleolar organizer regions in differentiating malignant from benign tumors of the colon. J. Clin. Pathol. 1990; 43: 235-8.
27. Sugai T. Biological significance of nucleolar organizer region-associated proteins (Ag-NORs) in adenomas and carcinomas of the colon. Jpn J. Gastroenterol. 1991; 88: 2749-56 (in Japanese).
28. Tanaka T, Takami T, Mori H, Takeuchi T, Nishikawa A. Nucleolar organizer regions in hepatocarcinogenesis induced by N-2-fluorenylacetamide in rats: Comparison with bromodeoxyuridine immunohistochemistry. Jpn J. Cancer Res. 1989; 11: 1052-7.
29. Kakeji Y, Korenaga D, Tsujitani S, Haraguchi M, Maehara Y, Sugimachi K. Predictive value of Ki-67 and argyrophilic nucleolar organizer regions staining for lymph node metastasis in gastric cancer. Cancer Res. 1991; 51: 3503-6.
30. David T, Fulvia F, Alessandra C, Claudio C, Vincenzo E, Massimo D. Ag-NORs area in interphase of human tumors correlate with the proliferative activity evaluated by bromodeoxyuridine labeling and Ki-67 immunostaining. J. Pathol. 1991; 165: 53-9.
31. Smith FG, Murray PG, Crocker J. Correlation between PCNA and Ag-NOR scores in non-Hodgkin's lymphomas using sequential staining technique. J. Clin. Pathol. 1993; 46: 28-31.
32. Kokai Y, Myers JN, Wada T et al. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 1989; 58: 287-92.
33. Shimada E, Urakawa T, Ueda T. Immunohistochemical study of the compression of epidermal growth factor receptor (EGFR) and c-erbB-2 protein in colorectal cancer. Jpn J. Gastroenterol. 1993; 90: 2889-94 (in Japanese).
34. Wright C, Angus B, Nicholson S et al. Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res. 1989; 49: 2087-90.